WASHINGTON, Jan. 22 (UPI) -- The Supreme Court heard argument Wednesday on whether states can force drug makers to extend to all patients price rebates usually reserved for Medicaid. An eventual decision in the case could affect pharmaceutical prices.
Advertisement